Exelixis
EXEL
#1773
Rank
C$13.74 B
Marketcap
$48.15
Share price
0.67%
Change (1 day)
65.41%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company